This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Innovations in Antimicrobial Peptides by Judith H Brown
Introduction
Judith H Brown is an accomplished inventor based in Falls Church, VA (US). She has made significant contributions to the field of antimicrobial peptides, particularly through her innovative research and development of modified peptide analogues.
Latest Patents
Judith H Brown holds a patent for "Antimicrobial magainin modified peptides." This invention focuses on designing and synthesizing peptides that exhibit improved broad-spectrum antimicrobial activity. The modified peptides are created by replacing low helical potential amino acid residues with high helical potential residues. Additionally, modifications to the termini enhance the amphiphilic structures and prolong antimicrobial activity by reducing susceptibility to protease degradation. For instance, residues such as Ser.sup.8, Gly.sup.13, and Gly.sup.18 in magainin II are modified with Ala, which has a higher propensity for helical structure. The patent demonstrates that these modified peptide analogues can exhibit an increase in antimicrobial activity by up to two orders of magnitude, while maintaining low hemolytic activity compared to magainin 1.
Career Highlights
Judith H Brown is associated with the United States of America as represented by the Department of Health. Her work has been pivotal in advancing the understanding and application of antimicrobial peptides in medical and pharmaceutical fields.
Collaborations
Judith has collaborated with notable researchers, including Hao-Chia Chen and John L Morell, to further her research in antimicrobial peptides.
Conclusion
Judith H Brown's innovative work in the field of antimicrobial peptides showcases her dedication to improving public health through scientific research. Her contributions have the potential to lead to significant advancements in antimicrobial therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
